Immunis Closes $10 Million Financing Round
/PRNewswire/ -- Immunis Inc., a private biotechnology company developing a novel treatment for age and disease-related immune decline, has closed a $10M Series...
Source: prnewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Screening Visit. Real-time updates on events, politics, business and more.